1. Home
  2. RAPP vs TFIN Comparison

RAPP vs TFIN Comparison

Compare RAPP & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPP
  • TFIN
  • Stock Information
  • Founded
  • RAPP 2022
  • TFIN 1981
  • Country
  • RAPP United States
  • TFIN United States
  • Employees
  • RAPP N/A
  • TFIN N/A
  • Industry
  • RAPP
  • TFIN Major Banks
  • Sector
  • RAPP
  • TFIN Finance
  • Exchange
  • RAPP Nasdaq
  • TFIN Nasdaq
  • Market Cap
  • RAPP 1.2B
  • TFIN 1.2B
  • IPO Year
  • RAPP 2024
  • TFIN N/A
  • Fundamental
  • Price
  • RAPP $25.93
  • TFIN $60.10
  • Analyst Decision
  • RAPP Strong Buy
  • TFIN Buy
  • Analyst Count
  • RAPP 3
  • TFIN 4
  • Target Price
  • RAPP $35.33
  • TFIN $62.00
  • AVG Volume (30 Days)
  • RAPP 441.3K
  • TFIN 297.7K
  • Earning Date
  • RAPP 11-07-2025
  • TFIN 10-15-2025
  • Dividend Yield
  • RAPP N/A
  • TFIN N/A
  • EPS Growth
  • RAPP N/A
  • TFIN N/A
  • EPS
  • RAPP N/A
  • TFIN 0.28
  • Revenue
  • RAPP N/A
  • TFIN $412,291,000.00
  • Revenue This Year
  • RAPP N/A
  • TFIN $12.07
  • Revenue Next Year
  • RAPP N/A
  • TFIN $14.74
  • P/E Ratio
  • RAPP N/A
  • TFIN $212.61
  • Revenue Growth
  • RAPP N/A
  • TFIN 3.78
  • 52 Week Low
  • RAPP $6.43
  • TFIN $42.90
  • 52 Week High
  • RAPP $42.27
  • TFIN $110.58
  • Technical
  • Relative Strength Index (RSI)
  • RAPP 52.13
  • TFIN 64.66
  • Support Level
  • RAPP $24.85
  • TFIN $57.24
  • Resistance Level
  • RAPP $27.17
  • TFIN $61.26
  • Average True Range (ATR)
  • RAPP 1.46
  • TFIN 2.75
  • MACD
  • RAPP -0.37
  • TFIN 1.58
  • Stochastic Oscillator
  • RAPP 49.28
  • TFIN 91.17

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.

Share on Social Networks: